Literature DB >> 15292341

The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults.

Elisabeth F C van Rossum1, Paul G Voorhoeve, Saskia J te Velde, Jan W Koper, Henriette A Delemarre-van de Waal, Han C G Kemper, Steven W J Lamberts.   

Abstract

Glucocorticoids play an important role in determining body composition. A polymorphism of the glucocorticoid receptor gene (in codons 22 and 23) has previously been found to be associated with relative glucocorticoid resistance, low cholesterol levels, and increased insulin sensitivity. In this study, we investigated whether this ER22/23EK polymorphism is associated with differences in body composition and muscle strength. We studied a cohort of 350 subjects who were followed from age 13 until 36 yr. We compared noncarriers and carriers of the ER22/23EK variant in anthropometric parameters, body composition, and muscle strength, as measured by arm pull tests and high jump from standing. We identified 27 (8.0%) heterozygous ER22/23EK carriers. In males at 36 yr of age, we found that ER22/23EK carriers were taller, had more lean body mass, greater thigh circumference, and more muscle strength in arms and legs. We observed no differences in body mass index or fat mass. In females, waist and hip circumferences tended to be smaller in ER22/23EK carriers at the age of 36 yr, but no differences in body mass index were found. Thus, the ER22/23EK polymorphism is associated with a sex-specific, beneficial body composition at young-adult age, as well as greater muscle strength in males.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292341     DOI: 10.1210/jc.2003-031422

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

Review 1.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome.

Authors:  Chiara Oretti; Sara Marino; Fabio Mosca; Maria Rosa Colnaghi; Sara De Iudicibus; Ilenia Drigo; Gabriele Stocco; Fiora Bartoli; Giuliana Decorti; Sergio Demarini
Journal:  Eur J Clin Pharmacol       Date:  2009-01-29       Impact factor: 2.953

Review 3.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

Review 4.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

5.  The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.

Authors:  Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 6.  Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Glucocorticoid receptor gene polymorphisms do not affect growth in fetal and early postnatal life. The Generation R Study.

Authors:  Miranda J J Geelhoed; Eric A P Steegers; Jan W Koper; Elisabeth F C van Rossum; Henriette A Moll; Hein Raat; Henning Tiemeier; Albert Hofman; Vincent W V Jaddoe
Journal:  BMC Med Genet       Date:  2010-03-03       Impact factor: 2.103

8.  CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training.

Authors:  Sean Walsh; Bethany K Kelsey; Theodore J Angelopoulos; Priscilla M Clarkson; Paul M Gordon; Niall M Moyna; Paul S Visich; Robert F Zoeller; Richard L Seip; Steve Bilbie; Paul D Thompson; Eric P Hoffman; Thomas B Price; Joseph M Devaney; Linda S Pescatello
Journal:  J Appl Physiol (1985)       Date:  2009-07-23

9.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

10.  The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy.

Authors:  Viktória Szabó; Gábor Borgulya; Tamás Filkorn; Judit Majnik; Ilona Bányász; Zoltán Zsolt Nagy
Journal:  Mol Vis       Date:  2007-04-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.